Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.

Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CA, Navani S, Uhlén M, O'Connor DP, Jirström K, Pontén F.

Am J Surg Pathol. 2011 Jul;35(7):937-48. doi: 10.1097/PAS.0b013e31821c3dae.

PMID:
21677534
2.

The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.

Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F.

Am J Clin Pathol. 2014 May;141(5):630-8. doi: 10.1309/AJCPWW2URZ9JKQJU.

PMID:
24713733
3.

[Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].

Lyn J, Wang Y, Wang F, Shen M, Zhou X.

Zhonghua Bing Li Xue Za Zhi. 2015 Aug;44(8):578-81. Chinese.

PMID:
26705182
4.

Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas.

Kim CJ, Baruch-Oren T, Lin F, Fan XS, Yang XJ, Wang HL.

J Clin Pathol. 2016 Dec;69(12):1046-1050. doi: 10.1136/jclinpath-2015-203588. Epub 2016 May 11.

PMID:
27169755
5.

SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma.

Ordóñez NG.

Adv Anat Pathol. 2014 Jan;21(1):63-7. doi: 10.1097/PAP.0000000000000001.

PMID:
24316906
6.

The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.

Perez Montiel D, Arispe Angulo K, Cantú-de León D, Bornstein Quevedo L, Chanona Vilchis J, Herrera Montalvo L.

Ann Diagn Pathol. 2015 Aug;19(4):249-52. doi: 10.1016/j.anndiagpath.2015.05.004. Epub 2015 May 21.

PMID:
26059401
7.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
9.
10.
11.

Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.

Yamagishi H, Imai Y, Okamura T, Fukuda K, Ono Y, Ban S, Inoue T, Ueda Y.

J Gastroenterol Hepatol. 2013 Dec;28(12):1815-22. doi: 10.1111/jgh.12319.

PMID:
23808938
12.

Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine.

Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, Wang HL, Liu H.

Arch Pathol Lab Med. 2014 Aug;138(8):1015-26. doi: 10.5858/arpa.2013-0452-OA. Epub 2014 Jan 17.

PMID:
24437456
13.

Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.

Bayrak R, Yenidünya S, Haltas H.

Pathol Res Pract. 2011 Mar 15;207(3):156-60. doi: 10.1016/j.prp.2010.12.005. Epub 2011 Feb 1.

PMID:
21282015
14.

Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.

Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C.

Int J Gynecol Pathol. 2016 May;35(3):191-208. doi: 10.1097/PGP.0000000000000238.

PMID:
26535987
15.

SATB2 is expressed in Merkel cell carcinoma.

Fukuhara M, Agnarsdóttir M, Edqvist PH, Coter A, Ponten F.

Arch Dermatol Res. 2016 Aug;308(6):449-54. doi: 10.1007/s00403-016-1655-6. Epub 2016 Jun 4.

PMID:
27262585
16.

Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.

Ikeda S, Fujimori M, Shibata S, Okajima M, Ishizaki Y, Kurihara T, Miyata Y, Iseki M, Shimizu Y, Tokumoto N, Ozaki S, Asahara T.

BMC Cancer. 2006 Feb 2;6:31.

17.

An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.

McCluggage WG, Kennedy K, Busam KJ.

Am J Surg Pathol. 2010 Apr;34(4):525-32. doi: 10.1097/PAS.0b013e3181d1d457.

PMID:
20182342
18.

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer.

Eberhard J, Gaber A, Wangefjord S, Nodin B, Uhlén M, Ericson Lindquist K, Jirström K.

Br J Cancer. 2012 Feb 28;106(5):931-8. doi: 10.1038/bjc.2012.34. Epub 2012 Feb 14.

19.
20.

Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.

D'Armento G, Daniele L, Mariani S, Ottaviani D, Mussa A, Cassoni P, Sapino A, Bussolati G.

Int J Surg Pathol. 2009 Apr;17(2):93-8. doi: 10.1177/1066896908328574. Epub 2008 Dec 12.

PMID:
19074466

Supplemental Content

Support Center